Biography
Matthijs Versteegh, PhD (Utrecht, The Netherlands, 1984) is director at the institute for Medical Technology Assessment (iMTA) at Erasmus University of Rotterdam. Matthijs holds an undergraduate in health sciences, and a master (cum laude) in science & technology studies (Maastricht University). He obtained his PhD in health economics on quantifying quality of life for economic evaluations of health from Erasmus University of Rotterdam. After completing his PhD, Matthijs worked for consultancy firm Ecorys (Dutch office) on projects for the European Commission (DG SANCO), the World Health Organisation (in Moldova and Kazakhstan), the World Bank (in India) and large regional variation studies for the Dutch board of Health Insurance (Zorginstituut Nederland). Matthijs is a member of the EuroQoL research foundation and the ‘Jonge Zorgdenktank’.
Erasmus School of Health Policy & Management
Visiting fellow | Health Technology Assessment (HTA)
- versteegh@eshpm.eur.nl
- Location
- Burg. Oudlaan 50, Rotterdam
More information
Work
- Irene Santi, Andrew J. Lloyd, Claudia E. Hastedt & Matthijs M. Versteegh (2023) - Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale - Advances in Therapy, 40 (9), 4060-4073 - doi: 10.1007/s12325-023-02553-7 - [link]
- Hamraz Mokri, Ingelin Kvamme, Linda de Vries, Matthijs Versteegh & Pieter van Baal (2023) - Future medical and non-medical costs and their impact on the cost-effectiveness of life-prolonging interventions: a comparison of five European countries - European Journal of Health Economics, 24 (5), 701-715 - doi: 10.1007/s10198-022-01501-6 - [link]
- Bram Wouterse, Pieter van Baal, Matthijs Versteegh & Werner Brouwer (2023) - The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice - PharmacoEconomics, 41 (6), 607-617 - doi: 10.1007/s40273-023-01265-8 - [link]
- Ayesha Sajjad, Matthijs Versteegh, Irene Santi, Jan Busschbach, Judit Simon & Leona van Roijen (2023) - In search of a ‘pan-European value set’; application for EQ-5D-3L - BMC Medical Research Methodology, 23 (1) - doi: 10.1186/s12874-022-01830-3 - [link]
- , Valérie van Hezik-Wester, Saskia de Groot, Tim Kanters, Matthijs Versteegh, Louis Wagner, Jacqueline Ardesch, Werner Brouwer & Job van Exel (2022) - Burden of illness in people with medically refractory epilepsy who suffer from daily to weekly seizures: 12-month follow-up of participants in the EPISODE study - Frontiers in Neurology, 13 - doi: 10.3389/fneur.2022.1012486 - [link]
- , Simone Huygens, Heleen Vellekoop, Matthijs Versteegh, Irene Santi, László Szilberhorn, Tamás Zelei, Balázs Nagy, Apostolos Tsiachristas, Rositsa Koleva-Kolarova, Sarah Wordsworth & Maureen Rutten-van Mölken (2022) - Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib - Value in Health, 26 (2), 193-203 - doi: 10.1016/j.jval.2022.08.006 - [link]
- Matthijs Versteegh, Ide van der Helm, Hamraz Mokri, Simone Oerlemans, Hedwig Blommestein & Pieter van Baal (2022) - Estimating Quality of Life Decrements in Oncology Using Time to Death - Value in Health, 25 (10), 1673-1677 - doi: 10.1016/j.jval.2022.06.002 - [link]
- Stefan A. Lipman, Arthur E. Attema & Matthijs M. Versteegh (2022) - Correcting for discounting and loss aversion in composite time trade-off - Health Economics, 31 (8), 1633-1648 - doi: 10.1002/hec.4529 - [link]
- , Heleen Vellekoop, Matthijs Versteegh, Simone Huygens, Isaac Corro Ramos, László Szilberhorn, Tamás Zelei, Balázs Nagy, Apostolos Tsiachristas, Rositsa Koleva-Kolarova, Sarah Wordsworth & Maureen Rutten-van Mölken (2022) - The Net Benefit of Personalized Medicine: A Systematic Literature Review and Regression Analysis - Value in Health, 25 (8), 1428-1438 - doi: 10.1016/j.jval.2022.01.006 - [link]
- , Rositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, Simone Huygens, Matthijs Versteegh, Maureen Rutten van Mölken, László Szilberhorn, Tamás Zelei, Balázs Nagy, Sarah Wordsworth & Apostolos Tsiachristas (2022) - Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options - Applied Health Economics and Health Policy, 20 (4), 501-524 - doi: 10.1007/s40258-021-00714-9 - [link]
f